Tacrolimus Appears to Be a Protective Factor for De Novo DSA Formation in Non-Sensitized Kidney Transplant Patients

被引：0
|
作者：
Marron-Wojewodzki, M. [1 ]
Szwarc, I. [1 ]
Rene, C. [2 ]
Mourad, G. [1 ]
Le Quintrec, M. [1 ,3 ]
机构：
[1] Hop Lapeyronie, Dept Nephrol Dialysis & Transplantat, Montpellier, France
[2] Hop St Eloi, Dept Immunol, Montpellier, France
[3] Hop St Eloi, IRMB, INSERM, U1183, Montpellier, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
10
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] Using Basiliximab Does Not Increase De Novo DSA Incidence but Reduces Cytomegalovirus Infections and Neoplastic Complications in Non-Sensitized Kidney Transplant Patients
    Marron-Wojewodzki, M.
    Szwarc, I.
    Rene, C.
    Eliaou, J. -F.
    Mourad, G.
    Le Quintrec, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 576 - 576
  • [2] A Low Level of De Novo DSA Sialylation is Associated with a Decreased of Allograft Survival in Non-Sensitized Kidney Transplant Recipients.
    Bonnet, M.
    Pernin, V.
    Serre, J-E
    Georgescu, V.
    Le Quintrec, M.
    Mourad, G.
    Eliaou, J-F
    Rene, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 442 - 442
  • [3] Analysis of Predictive and Preventive Factors for De Novo DSA in Non-HLA Sensitized Kidney Transplant Recipients.
    Hirai, T.
    Shibahara, R.
    Sawada, Y.
    Toki, D.
    Nozaki, T.
    Omoto, K.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 579 - 579
  • [4] Analysis of Predictive and Preventive Factors for De Novo DSA in Non-HLA Sensitized Kidney Transplant Recipients.
    Hirai, T.
    Shibahara, R.
    Sawada, Y.
    Toki, D.
    Nozaki, T.
    Omoto, K.
    Ishida, H.
    Tanabe, K.
    TRANSPLANTATION, 2014, 98 : 579 - 579
  • [5] Differential Alloimmune Response in Highly Sensitized and Non-Sensitized Kidney Transplant Recipients
    Negi, Sarita
    Rutman, Alissa
    Paraskevas, Steven
    Tchervenkov, Jean
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 89 - 89
  • [6] RENAL FUNCTION OUTCOMES IN DE NOVO KIDNEY TRANSPLANT RECEIVING TACROLIMUS WITH EVEROLIMUS AS A MAINTENANCE IMMUNOSUPPRESSION IN SENSITIZED PATIENTS WITH CPRA > 98% WITHOUT DONOR SPECIFIC ANTIBODIES (DSA)
    Cabello Pelegrin, Sheila
    Martinez Pomar, Natalia
    Alvaredo Beas, Fatima
    Gomez Marques, Gonzalo
    TRANSPLANT INTERNATIONAL, 2019, 32 : 279 - 279
  • [7] The Development and Impact of De Novo Circulating Antibodies in Non-Sensitized Patients after Heart Transplantation
    Patel, J.
    Kittleson, M.
    Rafiei, M.
    Osborne, A.
    Chang, D.
    Czer, L.
    Reinsmoen, N.
    Trento, A.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S86 - S86
  • [8] Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients
    Min, Sang-Il
    Ha, Jongwon
    Kim, Yon Su
    Ahn, Sang Hyun
    Park, Taejin
    Do Park, Dae
    Kim, Suh Min
    Min, Seung-Kee
    Hong, Hyejin
    Ahn, Curie
    Kim, Sang Joon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (12) : 3110 - 3119
  • [9] PATIENT WITH POST KIDNEY TRANSPLANT DE NOVO DSA AND STABLE GRAFT
    Monjo, Vanesa Cunill
    Cabello, Sheila
    Alvaredo, Fatima
    Martinez-Pomar, Natalia
    HLA, 2020, 95 (04) : 338 - 338
  • [10] Poor Outcome in Non-Sensitized Patients Developing De Novo Circulating Antibodies after Heart Transplantation
    Kobashigawa, J.
    Kittleson, M.
    Rafiei, M.
    Osborne, A.
    Chang, D.
    Czer, L.
    Reinsmoen, N.
    Patel, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 70 - 71
12345